Concerned about Gawande’s new venture, Optum sues over trade secrets

Concerned about Gawande’s new venture, Optum sues over trade secrets

More reads

• Concerned about Gawande's new venture, Optum sues over trade secrets. (STAT Plus)
• A flashy 2019 start to pharma M&A, but will it last? (BioPharma Dive)
• Novartis is taking a fresh approach to cancer treatment, and it could help prepare it for a 'doomsday scenario.' (Business Insider)